Epidemiology of endometrial cancer

Best Practice and Research: Clinical Obstetrics and Gynaecology

Volumn 15, Issue 3, 2001, Pages 341-354

  Purdie, David M ^a   Green, Adèle C ^a  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

Endometrial cancer; Epidemiology; Incidence; Risk factors

Indexed keywords

ESTROGEN; ORAL CONTRACEPTIVE AGENT; TAMOXIFEN;

BREAST CANCER; CANCER INCIDENCE; CANCER RISK; CANCER SURVIVAL; CLINICAL TRIAL; DIABETES MELLITUS; DISEASE ASSOCIATION; ENDOMETRIUM; ENDOMETRIUM CANCER; ESTROGEN BLOOD LEVEL; ESTROGEN THERAPY; EXERCISE; FEMALE; GYNECOLOGIC CANCER; HIGH RISK POPULATION; HORMONE SUBSTITUTION; HUMAN; LOW FAT DIET; MENARCHE; NULLIPARA; OBESITY; ORAL CONTRACEPTION; OVARY POLYCYSTIC DISEASE; POPULATION RESEARCH; POSTMENOPAUSE; PRIORITY JOURNAL; REPRODUCTION; REVIEW; RISK FACTOR; SMOKING;

EID: 0034942380     PISSN: 15216934     EISSN: None     Source Type: Journal    
DOI: 10.1053/beog.2000.0180     Document Type: Article

References (100)

1. Cancer statistics
2. Endometrial Cancer
3. Epidemiology of endometrial cancer
4. A case-control study of cancer of the endometrium
5. Recent and past use of conjugated estrogens in relation to adenocarcinoma of the endometrium
6. The joint effect of risk factors on endometrial cancer
7. Characteristics of noncontraceptive hormone users
8. Family history and the risk of endometrial cancer
9. A population-based study of endometrial cancer and familial risk in younger women. Cancer and Steroid Hormone Study Group
10. Risk factors among young women with endometrial cancer: A Danish case-control study
11. The risk of endometrial cancer in hereditary nonpolyposis colorectal cancer
12. The importance of family history in young patients with endometrial cancer
13. Reproductive, menstrual, and medical risk factors for endometrial cancer: Results from a case-control study
14. A case-control study of diabetes mellitus and cancer risk
15. Variations in the reporting of menstrual histories
16. A case-control study of endometrial cancer in relation to reproductive, somatometric, and life-style variables
17. Menstruation span - A time-limited risk factor for endometrial carcinoma
18. Reproductive factors and risk of endometrial cancer. The Iowa Women's Health Study
19. The epidemiology of endometrial cancer in young women
20. Marriage and childbearing in relation to cancer of the breast and uterus
21. Reproductive factors and risk of endometrial cancer
22. Childbearing at older age and endometrial cancer risk (Sweden)
23. Is the risk of cancer of the corpus uteri reduced by a recent pregnancy? A prospective study of 765 756 Norwegian women
24. Joint effects on cancer risk of age at childbirth, time since birth and attained age: Circumventing the problem on collinearity
25. Endometrial adenocarcinoma and the Stein-Leventhal syndrome
26. Granulosa-theca cell tumors and endometrial cancer: A study of their relationship and a survey of 80 cases
27. Endometrial adenocarcinoma and the polycystic ovary syndrome
28. Adenocarcinoma of the endometrium in women 40 years of age or younger
29. Serum estrogens and androgens in women with endometrial carcinoma
30. Hormone levels in healthy post-menopausal women and in women with post-menopausal bleeding with or without endometrial carcinoma
31. Noncontraceptive estrogens and progestins: Use patterns over time
32. Precursors of corpus cancer. III. The appearance of cancer of the endometrium in estrogenically conditioned patients
33. Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: Results of a prospective study
34. Endometrial cancer and patterns of use of oestrogen replacement therapy: A cohort study
35. Hormone replacement therapy and endometrial cancer risk: A meta-analysis
36. Estrogen and endometrial cancer: Cases and two control groups from North Carolina
37. Risk of localized and widespread endometrial cancer in relation to recent and discontinued use of conjugated estrogens
38. Risk of endometrial cancer following estrogen replacement with and without progestins
39. Risk of endometrial cancer in relation to use of low-dose, unopposed estrogens
40. Effects of progestins on estradiol receptor levels in human endometrium
41. Decline in incidence of endometrial cancer following increase in prescriptions for opposed conjugated estrogens in a prepaid health plan
42. Analysis of clinical susceptibility bias in case-control studies. Analysis as illustrated by the menopausal syndrome and the risk of endometrial cancer
43. Necropsy diagnosis of endometrial cancer and detection-bias in case/control studies
44. The influence of exogenous estrogen use on survival after diagnosis of endometrial cancer
45. Recency, duration, and progestin content of oral contraceptives in relation to the incidence of endometrial cancer (Washington, USA)
46. Use of oral contraceptives and endometrial cancer risk (Sweden)
47. Protection against endometrial carcinoma by combination-product oral contraceptives
48. Net effect of oral contraceptive use on the risk of cancer in women in the United States
49. Endometrial cancer in tamoxifen-treated breast cancer patients: Findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14
50. Iatrogenic risks of endometrial carcinoma after treatment for breast cancer in a large French case-control study. Federation Nationale des Centres de Lutte Contre le Cancer (FNCLCC)
51. Investigation of endometrial abnormalities in asymptomatic women treated with tamoxifen and an evaluation of the role of endometrial screening
52. Tamoxifen for early breast cancer: An overview of the randomised trials
53. Risk of endometrial cancer after tamoxifen treatment
54. Relationship between Quetelet's index and cancer of breast and female genital tract in 47 000 women followed for 25 years
55. Body mass index, weight gain, and risk of endometrial cancer
56. Diet, body size, physical activity, and the risk of endometrial cancer
57. Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer (Sweden)
58. Relation of endometrial cancer risk to past and contemporary body size and body fat distribution
59. Body fat patterning in women with endometrial cancer
60. Upper-body fat distribution and endometrial cancer risk
61. Adipose tissue distribution and female carcinomas. A 12-year follow-up of participants in the population study of women in Gothenburg, Sweden
62. Endometrial cancer, obesity, and body fat distribution
63. Peripheral aromatization as a risk factor for breast and endometrial cancer in postmenopausal women: A review
64. Free estradiol in postmenopausal women with and without endometrial cancer
65. Diabetes and endometrial cancer: An Italian case-control study
66. Oestrogens and endometrial cancer: Effect of other risk factors on the association
67. Hypertension and hormone-related neoplasms in women
68. Obesity as a disease
69. Insulin and endometrial cancer
70. Cigarette smoking and the risk of female reproductive cancer
71. Smoking, body weight, and early-stage endometrial cancer
72. Postmenopausal smoking, estrogen replacement therapy, and the risk of endometrial cancer
73. Smoking and risk of endometrial cancer: Results from an Italian case-control study
74. A case-control study of endometrial cancer in relation to cigarette smoking, serum estrogen levels, and alcohol use
75. Cigarette smoking and the risk of endometrial cancer
76. Oestrogen replacement treatment and the risk of endometrial cancer: An assessment of the role of covariates
77. Cigarette smoking and the risk of natural menopause
78. Effect of weight, smoking, and estrogen use on the risk of hip and forearm fractures in postmenopausal women
79. Smoking eliminates the protective effect of oral estrogens on the risk for hip fracture among women
80. Cigarette smoking and urinary estrogens
81. Serum steroid hormone profiles in postmenopausal smokers and nonsmokers
82. Cigarette smoking and steroid hormones in women
83. The effect of cigarette smoking on adrenal cortical hormones
84. Dietary factors and the risk of endometrial cancer
85. A population-based case-control study of dietary factors and endometrial cancer in Shanghai, People's Republic of China
86. Diet and endometrial cancer: A case-control study
87. Association of soy and fiber consumption with the risk of endometrial cancer
88. Estrogen excretion patterns and plasma levels in vegetarian and omnivorous women
89. The relationship among adiposity, diet, and hormone concentrations in vegetarian and nonvegetarian postmenopausal women
90. Diet and female sex hormone concentrations: An intervention study for the type of fat consumed
91. Diet and urine estrogens among postmenopausal women
92. Alcohol and other dietary factors in relation to serum hormone concentrations in women at climacteric
93. Moderate alcohol consumption and the risk of endometrial cancer
94. Lifestyle and endometrial cancer risk: A cohort study from the Swedish Twin Registry
95. Alcohol and endometrial cancer risk: Findings from an Italian case-control study
96. The epidemiology of serum sex hormones in postmenopausal women
97. Selected physical activities and the risk of endometrial cancer